Endolymphatic stromal myosis

Jacobsen, K; Haram, Kjell

doi:10.1007/bf00433243

Cited by 17 publications

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy

Gloor

Schnyder

Cikes

et al. 1982

Cancer

View full text Add to dashboard Cite

This report describes the clinicopathologic features of a 49‐year‐old woman who was reoperated on for bulky abdominal metastases 20 years after hysterectomy for endometrial stromal myosis (ESM). The levels of estrogen (ER) and progesterone (PR) receptors measured in the resected tumorous tissue amounted to 48.3 and 71.4 femtomoles (fmol)/mg cytosol protein, respectively. After medroxyprogesterone acetate (Depo‐Provera; Upjohn) treatment of 16 months duration, the unresected pelvic tumor mass compressing the bladder and the left ureter had decreased in volume and hydroureteronephrosis had regressed. The efficacy of the therapy was monitored by computed tomography. Two years and nine months after surgery, the evolution of the tumor seems well‐controlled by continuous progestin therapy and the patient is living without symptoms. Cancer 50:1888‐1893, 1982.

show abstract

Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy

Gloor

Schnyder

Cikes

et al. 1982

Cancer

View full text Add to dashboard Cite

show abstract

Endometrioid stromal sarcomas of the ovary. A clinicopathologic analysis of 23 cases

Young

Prat

Scully

1984

Cancer

131

View full text Add to dashboard Cite

The clinical and pathologic features of 23 endometrioid stromal sarcomas of the ovary were analyzed. The patients' ages ranged from 20 to 76 years (average, 54 years). The most common presenting symptom was abdominal swelling or pain. In 12 cases the tumors were unilateral and in 11 cases they involved both ovaries. Four of the tumors were Stage I, nine Stage II, and eight Stage III; two were Stage IV because of the presence of pulmonary metastases. In nine of the cases there was a prior, synchronous or subsequent endometrial stromal sarcoma of the uterus. Nineteen tumors with less than 10 mitotic figures (MF) per 10 high power fields (HPF) were classified as low grade and the remaining four tumors with 12 to 30 MF per 10 HPF were designated as high grade. Only 2 of the 19 patients with low‐grade tumors are known to have died of their disease and 9 of those whose tumor had spread beyond the ovary at the time of presentation were alive one or more years postoperatively. Three of the four patients with high‐grade tumors died of their disease within 4 years. Cancer 53:1143‐1155, 1984.

show abstract

Mesenchymal Tumors of the Uterus

Norris¹,

Zaloudek²

1982

Pathology of the Female Genital Tract

View full text Add to dashboard Cite

Endolymphatic stromal myosis

Cited by 17 publications

References 19 publications

Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy

Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy

Endometrioid stromal sarcomas of the ovary. A clinicopathologic analysis of 23 cases

Mesenchymal Tumors of the Uterus

Contact Info

Product

Resources

About